BÜHLMANN fCAL® ELISA Citation:
Turvill J, Rook L, Rawle M, et al. Validation of a care pathway for the use of faecal calprotectin in monitoring patients with Crohn’s disease. Frontline Gastroenterology Published Online First: 30 January 2017. doi: 10.1136/flgastro-2016-100780.
BÜHLMANN fCAL® ELISA is FDA 510(k) cleared. For in vitro Diagnostic Use.